I am just gonna call out the white elephant in the room because everyone has seen the news about drug…
Ines Martins, PhD
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ines Martins, PhD
Aurinia and Lonza Join to Produce Voclosporin for Phase 3 Lupus Nephritis Trial, Possible Market Use
Aurinia Pharmaceuticals and Lonza have entered into a long-term manufacturing agreement over the active pharmaceutical ingredient (API) in …
Measuring the levels of a protein called epidermal growth factor — a promising kidney biomarker — in patients with lupus may…
A new research study exploring the effects of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) on hearing, cognition, and…
You probably have heard the phrase “Sex, Drugs and Rock ‘n’ Roll.” I was used to hearing it as…
I am on day 3 of recovery from a 5-day vacation. No, it was not a rave-filled party…
The Lupus Agencies of New York State (LANYS) recently announced another victory after Gov. Andrew Cuomo signed into the law the…
While my disease is doing better each day and I am feeling better with every treatment, there are…
The American Autoimmune Related Diseases Association (AARDA) recently announced its latest #AutoimmuneHeroes — its 22 Scientific Advisory Board (SAB) members…
The Lupus Research Alliance, newly formed from the merger of three different lupus groups, had its debut at the recent Inaugural Gala…